Nationwide Fund Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-8,892
| Closed | -$416K | – | 644 |
|
|
2017
Q3 | $416K | Sell |
8,892
-347
| -4% | -$16.2K | ﹤0.01% | 2272 |
|
|
2017
Q2 | $332K | Sell |
9,239
-3,071
| -25% | -$110K | ﹤0.01% | 2391 |
|
|
2017
Q1 | $379K | Buy |
12,310
+385
| +3% | +$11.9K | ﹤0.01% | 2295 |
|
|
2016
Q4 | $399K | Buy |
11,925
+1,517
| +15% | +$50.8K | ﹤0.01% | 2298 |
|
|
2016
Q3 | $277K | Hold |
10,408
| – | – | ﹤0.01% | 2466 |
|
|
2016
Q2 | $229K | Hold |
10,408
| – | – | ﹤0.01% | 2543 |
|
|
2016
Q1 | $306K | Sell |
10,408
-85
| -0.8% | -$2.5K | ﹤0.01% | 2325 |
|
|
2015
Q4 | $346K | Sell |
10,493
-8,366
| -44% | -$276K | ﹤0.01% | 2292 |
|
|
2015
Q3 | $682K | Hold |
18,859
| – | – | ﹤0.01% | 1923 |
|
|
2015
Q2 | $848K | Sell |
18,859
-3,795
| -17% | -$171K | ﹤0.01% | 1950 |
|
|
2015
Q1 | $694K | Buy |
22,654
+8,092
| +56% | +$248K | ﹤0.01% | 2088 |
|
|
2014
Q4 | $740K | Sell |
14,562
-26
| -0.2% | -$1.32K | ﹤0.01% | 1967 |
|
|
2014
Q3 | $577K | Sell |
14,588
-45
| -0.3% | -$1.78K | ﹤0.01% | 2131 |
|
|
2014
Q2 | $630K | Buy |
14,633
+3,815
| +35% | +$164K | ﹤0.01% | 2132 |
|
|
2014
Q1 | $433K | Buy |
10,818
+200
| +2% | +$8.01K | ﹤0.01% | 2120 |
|
|
2013
Q4 | $290K | Sell |
10,618
-99
| -0.9% | -$2.7K | ﹤0.01% | 2500 |
|
|
2013
Q3 | $246K | Buy |
10,717
+9,575
| +838% | +$220K | ﹤0.01% | 2562 |
|
|
2013
Q2 | $20K | Buy |
+1,142
| New | +$20K | ﹤0.01% | 3085 |
|